Published in J Mater Chem B Mater Biol Med on March 01, 2016
Manufacturing Cell Therapies Using Engineered Biomaterials. Trends Biotechnol (2017) 0.75
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Matrix elasticity directs stem cell lineage specification. Cell (2006) 43.00
Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol (2001) 11.53
Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol (2006) 8.81
Growth factors, matrices, and forces combine and control stem cells. Science (2009) 8.46
Engineering vascularized skeletal muscle tissue. Nat Biotechnol (2005) 7.73
The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater (2007) 6.86
Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol (2001) 6.76
Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature (2013) 5.43
Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater (2010) 5.36
Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med (2005) 5.24
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science (2013) 4.94
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater (2012) 4.10
Morphogen gradient interpretation. Nature (2001) 3.90
Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res (2011) 3.25
Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater (2008) 3.24
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater (2010) 3.11
Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol (2010) 2.97
Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol (2010) 2.89
Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci U S A (2003) 2.86
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov (2011) 2.58
3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater (2014) 2.54
Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A (2009) 2.48
Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods (2013) 2.14
A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials (2003) 2.04
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials (2013) 1.97
Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systems. Trends Biotechnol (2004) 1.93
The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials (2005) 1.75
Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One (2011) 1.73
Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol (2003) 1.63
Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment. Nat Commun (2014) 1.56
Direct freeform fabrication of seeded hydrogels in arbitrary geometries. Tissue Eng (2006) 1.55
Biophysical regulation of epigenetic state and cell reprogramming. Nat Mater (2013) 1.55
N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells (2006) 1.43
Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat Methods (2011) 1.42
Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials (2010) 1.42
Engineering the cell-material interface for controlling stem cell adhesion, migration, and differentiation. Biomaterials (2011) 1.41
A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc Natl Acad Sci U S A (2013) 1.38
Engineering bone tissue substitutes from human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 1.38
Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells (2011) 1.29
Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J Mol Cell Cardiol (2014) 1.23
Three-dimensional biomimetic patterning in hydrogels to guide cellular organization. Adv Mater (2012) 1.19
BIOMIMETIC GRADIENT HYDROGELS FOR TISSUE ENGINEERING. Can J Chem Eng (2010) 1.17
Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol Sci (2009) 1.16
An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart. Biomaterials (2010) 1.16
Human mesenchymal stem cell differentiation on self-assembled monolayers presenting different surface chemistries. Acta Biomater (2009) 1.16
Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J (2013) 1.15
One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating. PLoS One (2012) 1.12
Engineered polymer-media interfaces for the long-term self-renewal of human embryonic stem cells. Biomaterials (2011) 1.11
Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix. Eur Cell Mater (2012) 1.11
Influence of physical properties of biomaterials on cellular behavior. Pharm Res (2011) 1.08
A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. Sci Rep (2013) 1.07
Coculture of human embryonic stem cells and human articular chondrocytes results in significantly altered phenotype and improved chondrogenic differentiation. Stem Cells (2009) 1.06
Biodegradable poly(ethylene glycol)-peptide hydrogels with well-defined structure and properties for cell delivery. Biomaterials (2008) 1.05
Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model. Cell Rep (2014) 1.01
Human Induced Pluripotent Stem Cell-Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation. J Am Soc Nephrol (2015) 0.97
Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A (2004) 0.96
The billion cell construct: will three-dimensional printing get us there? PLoS Biol (2014) 0.96
Engineering cell-material interfaces for long-term expansion of human pluripotent stem cells. Biomaterials (2012) 0.94
A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells. PLoS One (2012) 0.93
An ECM-based culture system for the generation and maintenance of xeno-free human iPS cells. Biomaterials (2012) 0.91
Mineralized gelatin methacrylate-based matrices induce osteogenic differentiation of human induced pluripotent stem cells. Acta Biomater (2014) 0.91
Dynamic Electromechanical Hydrogel Matrices for Stem Cell Culture. Adv Funct Mater (2011) 0.89
Effect of scaffold microarchitecture on osteogenic differentiation of human mesenchymal stem cells. Eur Cell Mater (2013) 0.89
Bone tissue engineering of induced pluripotent stem cells cultured with macrochanneled polymer scaffold. J Biomed Mater Res A (2012) 0.85
A novel culture technique for human embryonic stem cells using porous membranes. Stem Cells (2007) 0.85
Osteocyte differentiation is regulated by extracellular matrix stiffness and intercellular separation. J Mech Behav Biomed Mater (2013) 0.83
In vivo comparison of biomineralized scaffold-directed osteogenic differentiation of human embryonic and mesenchymal stem cells. Drug Deliv Transl Res (2016) 0.82
Patterning vascular networks in vivo for tissue engineering applications. Tissue Eng Part C Methods (2015) 0.82
Bioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation. Biofabrication (2014) 0.82
Biomineralized matrix-assisted osteogenic differentiation of human embryonic stem cells. J Mater Chem B Mater Biol Med (2014) 0.81
Poly(ethylene glycol) hydrogels with cell cleavable groups for autonomous cell delivery. Biomaterials (2015) 0.81
Biomimetic Material-Assisted Delivery of Human Embryonic Stem Cell Derivatives for Enhanced In Vivo Survival and Engraftment. ACS Biomater Sci Eng (2015) 0.78
Stem cells in pathobiology and regenerative medicine. J Pathol (2009) 0.77
Progress and bottleneck in induced pluripotency. Cell Regen (Lond) (2012) 0.76
Pluripotent stem cells as a platform for cardiac arrhythmia drug screening. Curr Treat Options Cardiovasc Med (2014) 0.76